At5g17730 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Specificity

The At5g17730 Antibody (Product Code: CSB-PA290523XA01DOA) is a polyclonal antibody designed to detect the protein product of the At5g17730 gene in Arabidopsis thaliana. This gene locus encodes a protein with the UniProt identifier Q9FN78, though its exact biochemical function remains uncharacterized . The antibody’s specificity arises from its paratope structure, which binds to epitopes unique to the At5g17730 protein .

Research Applications

The At5g17730 Antibody is utilized in multiple experimental workflows:

ApplicationMethodologyPurpose
Western BlottingProtein separation and detectionQuantify At5g17730 protein expression under varying conditions .
ImmunofluorescenceCellular localization via microscopyMap subcellular distribution of At5g17730 in plant tissues .
ELISAQuantitative antigen detectionMeasure protein levels in mutant vs. wild-type Arabidopsis lines .

Validation and Quality Control

While specific validation data for this antibody are not publicly disclosed, industry standards suggest:

  • Specificity: Verified via knockout/knockdown Arabidopsis lines to confirm absence of cross-reactivity .

  • Batch Consistency: Ensured through mass spectrometry (MS) and size-exclusion chromatography (SEC) .

Potential Research Findings

Though direct studies using this antibody are not cited in available literature, analogous research on Arabidopsis antibodies reveals:

  • Role in Stress Pathways: Antibodies against uncharacterized proteins often uncover roles in abiotic stress (e.g., drought, salinity) through expression profiling .

  • Developmental Regulation: Proteins detected by such antibodies may influence root or shoot development, as seen in related studies .

Limitations and Future Directions

  • Knowledge Gaps: The absence of published studies directly using this antibody highlights the need for functional characterization.

  • Technical Advancements: Integration with structure-based design tools like AntiFold could enhance epitope affinity in future iterations .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At5g17730 antibody; MVA3.9 antibody; AAA-ATPase At5g17730 antibody; EC 3.6.1.3 antibody
Target Names
At5g17730
Uniprot No.

Q&A

What is AT5G17730 and why is it important in plant research?

AT5G17730 encodes a P-loop containing nucleoside triphosphate hydrolases superfamily protein in Arabidopsis thaliana with significant enrichment (8.0 fold) in WRKY33 transcription factor binding studies . This protein belongs to a family involved in ATP binding and hydrolysis, playing potential roles in stress responses. Understanding its function through antibody-based detection helps elucidate plant stress response pathways, particularly in submergence conditions where it has been identified as a WRKY33 target gene.

What types of antibodies are most suitable for AT5G17730 protein detection?

For AT5G17730 protein detection, both polyclonal and monoclonal antibodies have specific applications. Polyclonal antibodies offer broad epitope recognition but with potential cross-reactivity issues. Monoclonal antibodies provide higher specificity for distinct epitopes. For studying protein complexes involving AT5G17730, specialized approaches similar to those used for protein complexes like BTLA-HVEM may be necessary, where fusion proteins are created to maintain complex stability during antibody generation .

How can I validate the specificity of an AT5G17730 antibody?

Validation should follow a multi-step approach:

  • ELISA testing against purified AT5G17730 protein

  • Western blot analysis with plant tissue extracts (wild-type vs knockout lines)

  • Immunoprecipitation followed by mass spectrometry

  • Immunofluorescence comparing signal between control and knockout plants

Similar to methods used in other antibody studies, specificity can be determined through comparative binding assays that measure antibody binding to target versus non-target proteins .

What are the recommended sample preparation methods for AT5G17730 antibody applications?

Sample TypePreparation MethodBuffer CompositionConsiderations
Whole plant tissueFlash freezing, grinding in liquid N₂50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, protease inhibitorsInclude phosphatase inhibitors for phosphorylation studies
Cell suspensionGentle lysis with non-ionic detergentPBS with 0.1% NP-40Maintain temperature at 4°C throughout
Nuclear extractsNuclear isolation followed by salt extraction20mM HEPES pH 7.9, 420mM NaCl, 1.5mM MgCl₂, 0.2mM EDTA, 25% glycerolCritical for transcription factor interaction studies
Membrane fractionsDifferential centrifugation10mM Tris-HCl pH 7.4, 250mM sucrose, 1mM EDTAUseful for localization studies

How can ChIP-seq be optimized for studying AT5G17730 interaction with WRKY33 transcription factor?

Based on existing WRKY33 ChIP-seq protocols, optimizing ChIP-seq for AT5G17730 requires:

  • Crosslinking modification: Use 1% formaldehyde for 10 minutes at room temperature for efficient crosslinking of protein-DNA complexes

  • Chromatin fragmentation: Sonicate to achieve fragments of 100-400 bp as used in successful WRKY33 ChIP-seq experiments

  • Antibody selection: Use highly specific anti-AT5G17730 antibodies, potentially with epitope tags if working with transgenic plants

  • Enrichment analysis: Apply MACS2 program with a false discovery cutoff of 0.05, similar to methods that successfully identified AT5G17730 as a WRKY33 target

  • Peak validation: Verify binding sites using techniques like ChIP-qPCR focused on the promoter regions containing the "TC box" (TCTCTC) motif identified in WRKY33 binding studies

What approaches can be used to study AT5G17730 protein complex formation under stress conditions?

To investigate AT5G17730 protein complexes:

  • Co-immunoprecipitation with stabilizing crosslinkers is recommended to preserve transient interactions triggered by stress.

  • Consider a fusion protein approach similar to that developed for the BTLA-HVEM complex, which successfully maintained complex integrity during antibody production .

  • Blue native PAGE can separate intact protein complexes while maintaining their native state.

  • Proximity-based labeling methods like BioID can identify transient interaction partners.

  • For in vivo validation, bimolecular fluorescence complementation (BiFC) provides visualization of protein interactions in plant cells.

The choice of method should account for the potentially transient nature of stress-induced interactions, as observed in other stress-responsive protein complexes.

How can I develop monoclonal antibodies against specific epitopes of AT5G17730?

Developing highly specific monoclonal antibodies for AT5G17730 requires a strategic approach:

  • Epitope selection: Identify unique, surface-exposed regions of AT5G17730 using structural prediction tools, focusing on domains that are distinct from other P-loop containing proteins

  • Immunization strategy: Use either synthetic peptides or recombinant protein fragments as immunogens

  • Hybridoma screening: Implement a multi-tier screening approach combining ELISA, western blot, and functional assays

  • Clonotype analysis: Sequence antibody variable regions to identify distinct clonotypes, as performed in IL17A antibody isolation studies

  • Neutralization assessment: If developing antibodies to block protein function, establish cell-based assays to evaluate functional neutralization

Research on mining autoantibody repertoires demonstrates that multiple rounds of selection can yield antibodies with diverse binding properties and functional characteristics .

What novel techniques can be applied to study AT5G17730 post-translational modifications?

For studying post-translational modifications (PTMs) of AT5G17730:

PTM TypeDetection MethodAdvantagesLimitationsReference Technique
PhosphorylationPhospho-specific antibodies combined with mass spectrometryDirect detection of specific phosphorylation sitesRequires site-specific antibodiesSimilar to approaches used for xylem-specific cellulose synthase phosphorylation analysis
UbiquitinationTandem ubiquitin binding entities (TUBEs) followed by immunoprecipitationEnriches ubiquitinated proteinsMay not distinguish between different ubiquitin chain typesAdaptable from RING/U-box protein studies
SUMOylationSUMO-trap pulldown with mass spectrometryCaptures transiently SUMOylated proteinsBackground binding issuesBased on techniques used for stress-responsive protein studies
GlycosylationLectin affinity chromatography combined with antibody detectionIdentifies specific glycan structuresComplex interpretation of resultsSimilar to approaches in PNGase F treatment studies

How can I address cross-reactivity issues with AT5G17730 antibodies?

Cross-reactivity can be systematically addressed through:

  • Absorption controls: Pre-absorb antibody with recombinant AT5G17730 protein to confirm specificity

  • Knockout validation: Compare antibody reactivity in wild-type versus AT5G17730 knockout plants

  • Epitope mapping: Identify precisely which regions of the protein are recognized by the antibody

  • Western blot optimization: Adjust blocking conditions (5% milk versus 3% BSA) and increase wash stringency

  • Immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody

These approaches are conceptually similar to those used in other antibody specificity studies, such as those performed with IgLON5 antibodies where glycosylation factors were systematically evaluated .

What are the potential causes and solutions for inconsistent AT5G17730 antibody signals in stress response experiments?

ProblemPossible CausesSolutionsValidation Method
Signal variability between replicatesInconsistent stress applicationStandardize stress treatment protocols; use controlled environment chambersInclude internal controls for stress markers
Signal loss after certain treatmentsProtein degradation during extractionAdd additional protease inhibitors; maintain cold chain; optimize extraction bufferSpike in known quantity of recombinant protein
Background signal in control samplesAntibody cross-reactivityIncrease antibody dilution; optimize washing steps; use alternative blocking agentsInclude peptide competition assay
Differential signal between tissue typesVariable expression or accessibilityOptimize extraction methods for each tissue type; consider native versus denaturing conditionsCompare with transcript levels via RT-qPCR
Loss of signal in time-course experimentsProtein turnover or epitope maskingSample at more frequent intervals; use multiple antibodies targeting different epitopesMonitor protein levels with alternative methods

How can I reconcile contradictory data between antibody-based detection and transcript levels of AT5G17730?

Discrepancies between protein and mRNA levels require systematic investigation:

  • Temporal dynamics: Implement time-course experiments with staggered sampling to account for delays between transcription and translation

  • Post-transcriptional regulation: Assess mRNA stability and translation efficiency through polysome profiling

  • Post-translational regulation: Investigate protein stability through cycloheximide chase experiments

  • Protein localization changes: Use subcellular fractionation to determine if changes in localization affect detection

  • Epitope masking: Test alternative antibodies targeting different regions of AT5G17730

This analytical approach resembles methods used to investigate discrepancies in WRKY33 regulated genes, where transcript levels and protein function showed distinct patterns during stress responses .

How can AT5G17730 antibodies be used to investigate submergence stress responses?

AT5G17730 antibodies can be integrated into submergence stress studies by:

  • Chromatin immunoprecipitation studies to determine if AT5G17730 directly interacts with submergence-responsive promoters containing the "TC box" (TCTCTC) motif identified in WRKY33 studies

  • Co-immunoprecipitation followed by mass spectrometry to identify interaction partners that change during submergence

  • Immunolocalization to track changes in subcellular distribution during stress

  • Quantitative western blot analysis to measure protein abundance changes in comparison to transcript level changes

  • Phosphorylation-specific antibody development to monitor stress-induced post-translational modifications

These approaches leverage the finding that AT5G17730 is a target of WRKY33 transcription factor binding during submergence stress, with an enrichment fold of 8.0 in ChIP-seq studies .

What experimental designs can determine if AT5G17730 forms functionally relevant protein complexes during oxidative stress?

To investigate AT5G17730 complex formation during oxidative stress:

  • Sequential co-immunoprecipitation: First pull down with AT5G17730 antibody, then with antibodies against suspected complex partners

  • Native gel electrophoresis with western blotting to preserve and detect intact complexes

  • Size-exclusion chromatography coupled with antibody detection to separate complexes by size

  • In situ proximity ligation assay to visualize protein interactions within plant cells

  • FRET/FLIM microscopy with fluorescently tagged proteins to detect direct interactions in vivo

This experimental approach is informed by studies of stress-responsive proteins involved in oxidation-reduction processes, which were identified as significant functional categories for WRKY33 target genes .

How can AT5G17730 antibodies be applied in studying plant immunity pathways?

Given that WRKY33 is a key regulator of plant immunity and AT5G17730 is a target gene, antibodies can be applied to understand immunity pathways through:

  • Monitoring protein abundance changes during pathogen infection compared to PAMP treatments

  • Investigating co-localization with known immune signaling components like NADPH oxidases

  • Analyzing protein modifications (phosphorylation, ubiquitination) during immune responses

  • Comparative studies between wild-type and defense-compromised mutants

  • Determining if AT5G17730 associates with nucleotide-binding leucine-rich repeat (NLR) receptor complexes

When designing these experiments, consider the approaches used in anti-cytokine autoantibody studies, where antibody neutralization assays provided insights into functional significance .

How might single-cell approaches be combined with AT5G17730 antibodies for spatial resolution of stress responses?

Integrating AT5G17730 antibodies with single-cell techniques:

  • Single-cell immunostaining with AT5G17730 antibodies combined with tissue clearing techniques can reveal cell-type specific expression patterns

  • Combining laser capture microdissection with immunoblotting allows for cell-type specific protein quantification

  • Proximity labeling (TurboID or APEX2 fused to AT5G17730) with cell-type specific promoters can identify interaction networks in specific cell populations

  • Spatial transcriptomics paired with in situ protein detection can correlate transcript and protein levels with high spatial resolution

  • Mass cytometry (CyTOF) with metal-conjugated antibodies enables multiplexed protein detection at single-cell resolution

These approaches extend beyond traditional immunolocalization to provide quantitative, spatially resolved data on AT5G17730 dynamics during stress responses.

What emerging antibody engineering techniques could enhance AT5G17730 research?

Novel antibody technologies that could advance AT5G17730 research include:

TechnologyApplicationAdvantageImplementation Consideration
Nanobodies (VHH antibodies)Intracellular immunoprecipitationSmall size allows better tissue penetration and intracellular expressionRequires specialized immunization of camelids or synthetic libraries
Bi-specific antibodiesSimultaneous detection of AT5G17730 and interaction partnersEnables co-detection without secondary antibody complicationsComplex production but can be achieved with recombinant techniques
SOMAmers (DNA aptamers)Non-antibody based detectionStable under harsh conditions; highly specificRequires extensive selection and validation process
Antibody fragments (Fab, scFv)Improved tissue penetrationReduced non-specific binding due to Fc removalMay have reduced affinity compared to full antibodies
Recombinant renewable antibodiesConsistent supply of identical antibodyEliminates batch-to-batch variationRequires initial hybridoma sequencing or phage display selection

Adapting techniques from human monoclonal antibody isolation, as demonstrated in the isolation of IL17A-specific antibodies , could be particularly valuable.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.